The new report by Claight Corporation titled, ‘Global Parasitic Diseases Therapeutics Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report and Forecast 2021-2026’, gives an in-depth analysis of the global parasitic diseases therapeutics market, assessing the market based on its segments like product and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents – https://tinyurl.com/43x469ef
The key highlights of the report include:
Market Overview (2016-2026)
- Forecast CAGR (2021-2026): 5.2%
Prophylactic treatment has increased mortality and morbidity due to protozoal and helminthic worm diseases. Preventive chemotherapy is used to monitor the spread of helminthic infections in a population. Because of the high prevalence of malaria around the world, researchers have been working on various vaccines to prevent the disease from spreading. In addition, researchers are working on a number of prophylactic vaccines to treat and prevent skin and visceral leishmaniasis. One of the main market developments on parasitic diseases, which would have a positive impact on market growth, is the increasing acceptance of these prophylactic vaccines for the prevention and control of parasitic diseases.
Industry Definition and Major Segments
Parasitic diseases such as amebiasis, African sleeping disease, trichomoniasis, giardiasis, trypanosomiasis, leishmaniasis, and malaria all need treatment.
On the basis of product, the parasitic diseases therapeutics market can be birfurcated into:
- Antiprotozoal Therapeutics
- Anthelminthic Therapeutics
- Scabicides And Pediculicides Therapeutics
On the basis of region, the market is segmented into:
- North America
- Latin America
- The Middle East and Africa
- The Asia Pacific
Infections with protozoa, helminths, and ectoparasites are becoming more common. The number of people infected with whipworms and hookworms grows every year. The number of cases of African trypanosomiasis has also risen significantly, especially in Sub-Saharan African countries such as Zambia, Tanzania, Uganda, and Malawi. Similarly, Chagas disease is common in parts of Central America, South America, and Mexico. Furthermore, schistosomiasis is becoming more common around the world. If these parasites become more common, there will be a greater need for parasite care. In 2020, the antiprotozoal therapeutics segment had the largest market share.
However, challenges such as antiparasitic drug discovery and disease diagnosis, as well as increased drug resistance, a lack of effective therapies, and side effects, could stymie the parasite diseases therapeutics industry’s growth in the coming years.
Read Full Report with Table of Contents – https://tinyurl.com/bdzjwdbf
Key Market Players
The major players in the market are Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc. (NYSE: PFE), Sanaria Inc. and Others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
We also provide state-of-the-art procurement intelligence through our platform, https://www.procurementresource.com. Procurement Resource is a leading platform for digital procurement solutions, offering daily price tracking, market intelligence, supply chain intelligence, procurement analytics, and category insights through our thoroughly researched and infallible market reports, production cost reports, price analysis, and benchmarking.
Informes de Expertos (https://www.informesdeexpertos.com), the Spanish variant of Expert Market Research, is a platform that offers market research and consultancy services to a broad clientele base across Spanish-speaking countries. With our primary focus on the Latin America and Spain markets, our research experts provide relevant and actionable insights into the markets and track major trends, economic developments, and global trade data.
Determined to bring client satisfaction, we make sure that our tailored approach meets the client’s unique market intelligence requirements. Our syndicated and customized research reports cover a wide spectrum of industries ranging from pharmaceuticals and food and beverage to packaging, logistics, and transportation.
Company Name: EMR Inc.
Contact Person: Sofia Williams, Business Consultant
Email: [email protected]
Toll Free Number: +1 (650) 761-6200 | +44 7441 392205
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Country: United States
Read More Reports:-
Primary Biliary Cholangitis Therapeutics Market : https://www.digitaljournal.com/pr/global-primary-biliary-cholangitis-therapeutics-market-to-be-driven-by-increasing-awareness-campaigns-in-the-forecast-period-of-2021-2026
Also Visit: https://expertmarketresearch-emr.blogspot.com/
Also, Check Procurement Intelligence which provides you with Infallible research solutions.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.